W. Larry Cash - Executive Vice President and Chief Financial Officer
Analyst · Darren Lehrich with Deutsche Bank
Thank you, Wayne. Our consolidated admissions were 164,437 in the third quarter 2008, adjusted admissions were 301,683 for the same period. Our same-store admissions increased 2.3% when adjusted for the factor of the two hurricanes affected operations Texas and Louisiana and the flooding in the Illinois hospitals admissions would have increased 2.6%. Same-store admissions increased 2.5%. Same-store self-pay admissions increased only 1.4% year-over-year decreased 10 basis points as a percentage of total admissions to 6.6%. Net revenues in the third quarter were $2.773 billion, an increase of over 23%. On a same-store basis net revenue increased 8.2%. In-patient revenue increased 9.6% and out-patient revenue increased 7.4%. Same-store net revenue per adjusted admission increased 5.5% year-over-year and also increased to 2.4% on a sequential basis. Same-store surgery volume increased 1.8% for the third quarter turning positive with a larger increase in out-patient. Our Medicare case mix was down slightly for the quarter. Our Medicare case mix improved approximately two-tenths when comparing year to date. The Medicare case mix for the quarter was somewhat down because we had faster growth in medical admissions versus surgical admissions. As with both the first and second quarters, same-store revenue growth continues to be affected by the implementation of the discount policy in our non-Tennessee Legacy hospitals in the first quarter this year. The impact of this implementation was approximately 100 basis points on both revenue and revenue per adjusted admission for the quarter. Same-store revenue would have increased 9.2% and same-store revenue for adjusted admission would have increased 6.5%, excluding the discount policy implementation. Consolidated EBITDA was $392.3 million for the quarter versus $300 million for the same period a year ago, an increase of 30.8%. On a same-store basis the value increased $107 million or 37.5% from $285 million to $392 million for the quarter. EBITDA margin for the third quarter on a consolidated basis is 14.1%, an 80 basis improvement from a year ago. Same-store EBITDA margin was 14.2 compared to 11.2 for the quarter ended September 30th, 2007. On a sequential basis the third quarter same-store margin improvements strong 40 basis points. For the third quarter our non-same-store margin from one de novo hospital was 0.06% negative margin. Consolidated operating expenses decreased 80 basis points with an 80-basis-point decline in payroll benefits. On a sequential basis we saw improvements in payroll and benefits supplies under operating expenses and increase in bad debt. Same-store operating expenses decreased 300 basis points for improvements in all expense categories. On a same-store operating costs increased 4.5% with an 8.2% increase in same-store revenue for quarter, again demonstrating our strong expense control, with operating costs per adjusted admission increasing only 1.9%. On a year-to-date basis consolidated admissions were 506,872 and adjusted admissions were 911,143. Same-store admissions increased 2.8% and adjusted admissions increased 2.9%. Adjusted for the flu, the extra leap day in February, service closures, statistical reclassifications, and other related hurricane items, as previously discussed same-store admissions would have been up 2.2%. Our volume guidance for 2009 is 1% to 2% and to point the original 2008 volume guidance was 0.5% and 1.5%. Net revenues year to date were $8.2 billion, an increase of 78%. On a same-store basis net revenue increased 6.3% for the first nine months. Same-store in-patient revenue was up 7.4% and out-patient revenue was up 5.8%. On a same-store basis net revenue per adjusted admission increased 3.2% and on a same-store surgery volume was up 0.2% year to date. Our Medicare case mix for the nine months ended was down 1.2% and again we are having faster medical procedure growth than surgical procedure growth. Same-store revenue growth continues to be affected by the implementation of discount policy in our Tennessee hospitals in the third quarter of 2007 and the non-Tennessee Legacy hospitals in the first quarter of 2008. The year-to-date impacted implementation was 120 basis points in both revenue and revenue per adjusted admission. Same-store revenue would have increased 6.2% and same-store revenue per adjusted admission would have increased 4.4% excluding the discount policy implementation. Consolidated EBITDA for the first nine months was $1.144 billion an increase of 79%. Same-store EBITDA was $1.137 billion for an increase of 18.9%. Consolidated EBITDA margins for nine months ended September 30th, 2008 was 14% and same-store margin was 14.1% an increase of 150 basis points. Non-same-store margin was 5.2%. For the first nine months consolidated operating expenses percentage of net revenue improved 10 basis points. Prior year payroll and benefits decreased 20 basis points. Bad debt decreased 50 basis points. And other operating expenses decreased 80 basis points offset by an increase of supplies of 140 basis points. Same-store operating expenses improved 150 basis points from 2007. Our payroll productivity or per man-hours adjusted admission 200 basis points. Our operating cost per adjusted admission increased 1.5% for the nine months ended September 30th, 2008 demonstrating our strong expense management ability. For the quarter consolidated bad debts decreased 10 basis points 11.8% versus 11.9%. For the quarter our bad debt increased 9 basis points versus the first six months. Self-pay admissions of like total admissions growth increased in bad debts has been driven by the growth of primarily out-patient revenue related to our increase in prices during 2008 and a decrease in the patients recognized as charity in the third quarter. When charges increase, revenue increases but so does, bad debt for self-pay. Or consolidated bad debt charity administrative self-pay discounts divided by adjusted net revenue is 18% for the quarter and 17.6% year to date. Our combined consolidated bad debt charity administrative discounts as a percentage of adjusted revenue are down 10 basis points for the quarter and 40 basis points year to date. Revenue minus bad debts was up 8.9% for the quarter for operating expenses minus bad debts were up 4.7% for the quarter. Year-to-date revenue minus bad debt was up 6.5% and operating expenses minus bad debt was up 4.4%. As we have consistently said the real cost accreting to self-insured is represented by incremental cost of care. Our same-store operating costs per adjusted admission increased only 1.9% for the third quarter and 1.5% on a year-to-date basis. Consolidated cash receipts were approximately 103% of collectible net revenue which is net revenue less bad debts for the last 12 months ended September 30, 2008. Our 2009 guidance for bad debt ranges from 11.8% to 12.4% of net revenue compared to the current 2008 guidance of 11.2% to 11.5%. Total AR days were 54, September 30, 2008 unchanged from December 31, 2007. Same-store AR days were also 54 the quarter. The allowance for dapple [ph] counts is 1.109 billion at the end of the quarter or 40.3% of receivables. The allowance for dapple counts and related contractual allowances for self-pay was approximately 80% of the hospital segment of self-paid receivables at September 30th, 2008. Community Health System continues to have a favorable payer mix recorded in September 30th, 2008 net revenue by payer source on a consolidated basis was as follows. Medicare 26.2%, Medicaid 9.3%, managed care and other 53.3%, and self-pay 11.2% of revenue. On a year-to-date basis the breakdown was as follows. Medicare 27.4%; Medicaid 8.8%; managed care and other 52.8%, and self pay 11%. Cash flow from operations for the third quarter was a strong $268 million versus $189 million in the same quarter a year ago. Cash flow from operations for the first nine months was $685 million compared to $405 million for the same period in 2007 an increase of $276 million. An increase in cash flow from operation compared to the prior year reflects improved profitability noted by increase of net income, increase of non-cash depreciation expense, increase in cash flow and change of accounts payable accrued liabilities and other income taxes and an increase from tax refunds from prior periods. These cash flows were offset by decreasing cash flows by a net increase in accounts receivable primarily from the same-store growth. We have increased our 2008 guidance from $750 million to $800 million for net cash provided by our operating activities to a range of $800 million to $850 million, our 2009 guidance is $850 million to $900 million. Capital expenditures for quarter just ended were $176 million, year to date we spent $51 billion or 5% of that revenue. This amount includes $122 million or about 1.5% for replacement hospitals. We lowered our 2008 guidance which was 725 to 775 by approximately $50 million at the low end of the range and $25 million in the high end of the range. Our 2009 guidance CapEx would be $750 million or 5.9 to 6.2% of that revenue. Balance sheet cash as of September 30th was $342 million and we purchased a Spokane on October 1st which reduced the cash about $160 million. As of September 30th, 2008 the company had available credit from the revolver of $700 million and $300 million available due to the late draw that will be drawn before the end of January 2009. Looking at the balance sheet as of September 30th, 2008. We had $1.223 billion working capital and $13.6 billion in total assets total outstanding debt at September 30th was $8.9 billion of which approximately 88% was fixed. Our debt to capitalization at the quarter end was 82.6%. We have repurchased $69 million or 3,017,000 shares through late October. During October we also bought $42.8 million of our 8.78 coupons bonds back in the open market. Our credit rate does limit the amount of stock and bonds that we can repurchase. Our senior subordinated notes mature on July 15th, 2015 our bank facility matures one year earlier 2014. One of our slides, number 18, just gives some history. Our debt to net revenue was approximately 1.6 times in 1996 after a leveraged buyout of [inaudible] and 0.5 times in 2006. After the Triad acquisition our debt to net revenue is 0.8 times. On a debt to EBITDA basis the company was 9.3 times levered in 1996, 3.4 times in 2006 and approximately 5.9 times estimated for 2008 after the Triad acquisitions. These statistics demonstrate our ability for deleveraging. At the end of September we were party to a $4.85 billion in interest rates swap agreements an increase of $400 million from the end of June. These agreements limit the factor change interest rates on a portion of our long-term borrowings. Since September 30 we have added additional $300 million in swaps and are now a party to $150 billion in swaps. As of October 28th approximately 91% of our debt is now fixed. As Wayne stated here early we provided our 2009 guidance and please note the following items. Our 2009 guidance includes a 5% to 6% increase in same-store revenue. The guidance includes two outstanding letter of intents of hospitals in Pennsylvania and Arkansas and an additional facility, 2009 interest expense range from 5.6% to 5.9% of revenue, our 2009 cash and operating guidance is $850 million to $900 million, the CapEx guidance for 2009 is $700 million to $750 million. This represents approximately 6% of net revenue for the coming year, a decrease from 2008 due somewhat to the no replacement hospitals plan for 2009. Depreciation and amortization are projected to be 4.5% to 4.8% of net revenue for 2009. The 2009 projection assumes an estimate of $0.02 to $0.03 per share of acquisition costs that will now need to be expensed due to the new accounting rules for business combinations. The EPS guidance of 2.20 to 2.26 for 2008 does include the impact of Indiana Medicaid adjustments, hurricanes in the third quarter collectively of about $0.06 for our periods. It should be noted that if you annualized the EPS from July of 2007 through December 2007, annual 2007 EPS would be about $1.50 per share indicating substantial improvements achieved in earnings per share for 2008 to 2009 EPS guidance is $2.50 to $2.75. And Wayne will have brief recap.